Open Access
Subscription or Fee Access
An Experimental Study of Spherical Agglomeration of Benzoic acid And Influence of Process Parameters
Abstract
Through the process of drowning-out crystallisation in three partly miscible solvent mixtures, sphere aggregates of benzoic crystal have been successfully created. The mixture of benzoic acid, isopropyl alcohol, and bridging liquid is supplied to an agitated crystallizer with water acting as the anti-solvent. When a substance crystallises, little crystals are formed, and the bridging liquid causes the crystals to group together. Different solvents are utilised because benzoic acid crystals wettably adhere to chloroform, toluene, heptane, and pentane, which are all low solubility in water and chosen as bridge liquids. Investigated are the effects of process variables such solute concentration, temperature, stirring rate, processing duration, volume of bridging liquid, and stirring rate on the characteristics of spherical agglomerates of benzoic acid as part of the standard spherical crystallisation experiment, many sets of tests were carried out to monitor how the particle properties gradually changed. The current investigation demonstrates that the bridging liquid significantly affects the product qualities since it allows the formation of spherical agglomerates with four different solvents (chloroform, toluene, heptane, and pentane) when utilised in adequate quantities. When the BSR is 0.72, the particle morphology changes to become spherical; when toluene is employed as the bridging liquid, the particle morphology is totally spherical. With increasing temperature particle size is decreasing. Spherical agglomerates are obtained at 1100 rpm. At 5°C, particles became spherical. Morphology grew as temperature decreased.
References
Y. Kawashima. C.E. Capes. An experimental study of spherical agglomeration in a stirred vessel.1974; 10 (1–2) 85–92
Kawashima Y. Capes CE. Further studies of the kinetics of spherical agglomeration in a stirred vessel. Powder Technol. 1976; 13, 279–288.
Chow AHL, Leung MWM. A study of the mechanisms of wet spherical agglomeration of pharmaceutical powders. Drug DevIndPharma. 1996; 4, 357–371.
Muller M, Loffler F. Development of agglomerate size and structure during spherical agglomeration suspension. Part. Part. Syst. Charact. 1996; 13, 322–326.(6)
Holmbäck X, Rasmuson ÅC. Size and morphology of benzoic acid crystals produced by drowningout crystallization. J.Crystal Growth. 1999; 198-199, 780–788
Kawashima Y, Imai M, Takeuchi H, Yamamoto H, and Kamiya, K, Development of Agglomerated Crystals of Ascorbic acid by the Spherical Crystallization Technique for Direct Tableting, and
Evaluation of their Compactibilities, Kona. 2002; 20, 251–261.
Blandin AF, Mangin D, Rivoire A, Klein JP, Bossoutrot JM. Modeling of agglomeration in suspension: Application to salicylic acid microparticles. Powder Technol. 2005; 156, 19–33.
Subero CC, Mangin D, Rivoire A, Blandin AF, Klein JP. Agglomeration in suspension of salicylic acid fine particles: Analysis of the wetting period and effect of the binder injection mode on the
final agglomerate size. Powder Technol. 2006; 161, 98–109.
Oliveira CA, Coelho GM, Pires FR, Franco JR, Solubility of benzoic acid in mixed solvents. J. Chem. Eng. Data. 2007; 52, 298–300.
Kumar S, Chawla G, Bansal AK. Spherical crystallization of mebendazole to improve process ability. Pharm. Dev. Technol. 2008; 13, 559–568.
B. Kovačič, et al, Particle Size Reduction Technologies in the Pharmaceutical Development Process. Drug is Dichloromethane (DCM), Acta Phamaceutica Sinica B 2012; 1–14.
SumantSaini, ‘Spherical Crystallization: An Overview’, International Journal of Drug Delivery Technolog. 2017; 4(4).
J Thati, S Chintha, A Review on Spherical Crystallization Mechanisms and Characterization, Research Journal of Pharmacy and Technology 11 (1), 412-417, DOI:10.5958/0974– 360X.2018.00076.8
Refbacks
- There are currently no refbacks.